Ticker Scorecard - XERS Basics Company: Xeris Pharmaceuticals, Inc. IPO Date: June 22, 2018 Sector: Healthcare Market Cap: $559.06M Activated in VL: True Average Daily Range Avg Daily Range: $0.18 | 3.48% Avg Daily Range (30 D): $0.08 | 2.26% Avg Daily Range (90 D): $0.07 | 2.15% Institutional Daily Volume Avg Daily Volume: 1.36M Avg Daily Volume (30 D): 1.6M Avg Daily Volume (90 D): 1.48M Trade Size Avg Trade Size (Sh.): 243 Avg Trade Size (Sh.) (30 D): 175 Avg Trade Size (Sh.) (90 D): 186 Institutional Trades Total Inst.Trades: 208 Avg Inst. Trade: $1.59M Avg Inst. Trade (30 D): $.98M Avg Inst. Trade (90 D): $1.38M Avg Inst. Trade Volume: .42M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.89M Avg Closing Trade (30 D): $1.37M Avg Closing Trade (90 D): $.76M Avg Closing Volume: 757.78K     News May 9, 2024 @ 12:10 PM Xeris Biopharma (XERS) Reports Q1 Loss, Lags Reven... Source: Zacks Equity Research Apr 17, 2024 @ 11:24 AM Strength Seen in MediWound (MDWD): Can Its 14.3% J... Source: Zacks Equity Research Mar 30, 2024 @ 5:28 AM Xeris Biopharma: Checking-In On One Of My 'Top Ide... Source: Biologics Mar 5, 2024 @ 2:42 PM Why Xeris (XERS) Might Surprise This Earnings Seas... Source: Zacks Equity Research Jan 11, 2024 @ 1:30 PM Xeris (XERS) Up on Licensing Deal With Amgen to De... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.44 $-.11 $-.1 Diluted EPS $-.44 $-.11 $-.1 Revenue $ 187.36M $ 54.27M $ 48.07M Gross Profit $ $ $ Net Income / Loss $ -63.11M $ -15.74M $ -15.01M Operating Income / Loss $ -45.17M $ -12.89M $ -8.19M Cost of Revenue $ $ $ Net Cash Flow $ 12.79M $ 1.53M $ -5.09M PE Ratio